- Supported exchanges /
- NSE /
- NGLFINE.NSE
NGL Fine-Chem Limited (NGLFINE NSE) stock market data APIs
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. The company offers animal health pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine hcl, s-methoprene, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, carprofen, fenbendazole, and xylazine hydrochloride. It also offers human health pharmaceutical ingredients comprising of nitazoxanide and atovaquone; and intermediates and specialty chemicals consisting of trimethyl, triazacylononane, and ethyl glucamine. In addition, the company provides finished dosage forms comprising of diminazene aceturate granules and homidium chloride tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
NGL Fine-Chem Limited Financial Data Overview
| 1837.25 | |
| 1865.5 | |
| - | |
| 1865.5 | |
| 1807.65 | |
| 1702.35-2821.8271 | |
| 11 374 M | |
| 27.4329 | |
| 6 178 K | |
| 3 584 M | |
| 0.001 | |
| 1.08 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
NGL Fine-Chem Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 3 584 M
- EBITDA 526 M
- Earnings Per Share 67.04
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get NGL Fine-Chem Limited Earnings via APIs
- Latest Release 2024-11-08
- EPS/Forecast NaN
Get NGL Fine-Chem Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
